Differential expression and potential role of SOCS1 and SOCS3 in Wallerian degeneration in injured peripheral nerve

Experimental Neurology

Volumn 223, Issue 1, 2010, Pages 173-182

  Girolami, Elizabeth I ^a   Bouhy, Delphine ^a   Haber, Michael ^a   Johnson, Howard ^b   David, Samuel ^a  

^a RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

Cytokine; Inflammation; Macrophage; Peripheral nerve; SOCS; Wallerian degeneration

Indexed keywords

INTERLEUKIN 1BETA; JANUS KINASE 2; MESSENGER RNA; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 1; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME PHOSPHORYLATION; FEMALE; INFLAMMATION; MACROPHAGE; MOUSE; NERVE DEGENERATION; NERVE FIBER REGENERATION; NONHUMAN; PATHOGENESIS; PERIPHERAL NERVE INJURY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHWANN CELL; SCIATIC NERVE; SIGNAL TRANSDUCTION; SURGICAL INJURY;

ANIMALS; ANTIGENS, DIFFERENTIATION; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; GENE EXPRESSION REGULATION; JANUS KINASE 2; MACROPHAGES; MICE; MICE, INBRED BALB C; NERVE GROWTH FACTORS; PHOSPHORYLATION; RNA, MESSENGER; S100 PROTEINS; SCHWANN CELLS; SCIATIC NEUROPATHY; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS; WALLERIAN DEGENERATION;

EID: 77950857433     PISSN: 00144886     EISSN: 10902430     Source Type: Journal    
DOI: 10.1016/j.expneurol.2009.06.018     Document Type: Article

References (73)

1. Alexander W.S. Suppressors of cytokine signalling (SOCS) in the immune system. Nat. Rev. Immunol. 2002, 2:410-416.
2. Alexander W.S., Hilton D.J. The role of suppressors of cytokine signaling (SOCS) proteins in regulation of the immune response. Annu. Rev. Immunol. 2004, 22:503-529.
3. Barrette B., Hebert M.A., Filali M., Lafortune K., Vallieres N., Gowing G., Julien J.P., Lacroix S. Requirement of myeloid cells for axon regeneration. J. Neurosci. 2008, 28:9363-9376.
4. Be'eri H., Reichert F., Saada A., Rotshenker S. The cytokine network of Wallerian degeneration: IL-10 and GM-CSF. Eur. J. Neurosci. 1998, 10:2707-2713.
5. Bendszus M., Stoll G. Caught in the act: in vivo mapping of macrophage infiltration in nerve injury by magnetic resonance imaging. J. Neurosci. 2003, 23:10892-10896.
6. Berlato C., Cassatella M.A., Kinjyo I., Gatto L., Yoshimura A., Bazzoni F. Involvement of suppressor of cytokine signaling-3 as a mediator of the inhibitory effects of IL-10 on lipopolysaccharide-induced macrophage activation. J. Immunol. 2002, 168:6404-6411.
7. Biethahn S., Alves F., Wilde S., Hiddemann W., Spiekermann K. Expression of granulocyte colony-stimulating factor- and granulocyte-macrophage colony-stimulating factor-associated signal transduction proteins of the JAK/STAT pathway in normal granulopoiesis and in blast cells of acute myelogenous leukemia. Exp. Hematol. 1999, 27:885-894.
8. Boivin A., Pineau I., Barrette B., Filali M., Vallieres N., Rivest S., Lacroix S. Toll-like receptor signaling is critical for Wallerian degeneration and functional recovery after peripheral nerve injury. J. Neurosci. 2007, 27:12565-12576.
9. Bolin L.M., Verity A.N., Silver J.E., Shooter E.M., Abrams J.S. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J. Neurochem. 1995, 64:850-858.
10. Bourde O., Kiefer R., Toyka K.V., Hartung H.P. Quantification of interleukin-6 mRNA in Wallerian degeneration by competitive reverse transcription polymerase chain reaction. J. Neuroimmunol. 1996, 69:135-140.
11. Cafferty W.B., Gardiner N.J., Gavazzi I., Powell J., McMahon S.B., Heath J.K., Munson J., Cohen J., Thompson S.W. Leukemia inhibitory factor determines the growth status of injured adult sensory neurons. J. Neurosci. 2001, 21:7161-7170.
12. Chinen T., Kobayashi T., Ogata H., Takaesu G., Takaki H., Hashimoto M., Yagita H., Nawata H., Yoshimura A. Suppressor of cytokine signaling-1 regulates inflammatory bowel disease in which both IFNgamma and IL-4 are involved. Gastroenterology 2006, 130:373-388.
13. Chong M.M., Metcalf D., Jamieson E., Alexander W.S., Kay T.W. Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 2005, 106:1668-1675.
14. Croker B.A., Krebs D.L., Zhang J.G., Wormald S., Willson T.A., Stanley E.G., Robb L., Greenhalgh C.J., Forster I., Clausen B.E., Nicola N.A., Metcalf D., Hilton D.J., Roberts A.W., Alexander W.S. SOCS3 negatively regulates IL-6 signaling in vivo. Nat. Immunol. 2003, 4:540-545.
15. Croker B.A., Kiu H., Nicholson S.E. SOCS regulation of the JAK/STAT signalling pathway. Semin. Cell Dev. Biol. 2008, 19:414-422.
16. Curtis R., Scherer S.S., Somogyi R., Adryan K.M., Ip N.Y., Zhu Y., Lindsay R.M., DiStefano P.S. Retrograde axonal transport of LIF is increased by peripheral nerve injury: correlation with increased LIF expression in distal nerve. Neuron 1994, 12:191-204.
17. David S., Braun P.E., Jackson D.L., Kottis V., McKerracher L. Laminin overrides the inhibitory effects of peripheral nervous system and central nervous system myelin-derived inhibitors of neurite growth. J. Neurosci. Res. 1995, 42:594-602.
18. Dickensheets H.L., Donnelly R.P. Inhibition of IL-4-inducible gene expression in human monocytes by type I and type II interferons. J. Leukoc. Biol. 1999, 65:307-312.
19. Ding Y., Chen D., Tarcsafalvi A., Su R., Qin L., Bromberg J.S. Suppressor of cytokine signaling 1 inhibits IL-10-mediated immune responses. J. Immunol. 2003, 170:1383-1391.
20. Donato R., Cheema S., Finkelstein D., Bartlett P., Morrison W. Role of leukaemia inhibitory factor (LIF) in rat peripheral nerve regeneration. Ann. Acad Med. Singapore 1995, 24:94-100.
21. Egan P.J., Lawlor K.E., Alexander W.S., Wicks I.P. Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J. Clin. Invest. 2003, 111:915-924.
22. Elliott J., Johnston J.A. SOCS: role in inflammation, allergy and homeostasis. Trends Immunol. 2004, 25:434-440.
23. Feroze-Merzoug, F., Berquin, I.M., Dey, J., and Chen, Y.Q., 2002. Peptidylprolyl isomerase A (PPIA) as a preferred internal control over GAPDH and beta-actin in quantitative RNA analyses. Biotechniques. 32:776-8, 780, 782.
24. Flowers L.O., Johnson H.M., Mujtaba M.G., Ellis M.R., Haider S.M., Subramaniam P.S. Characterization of a peptide inhibitor of Janus kinase 2 that mimics suppressor of cytokine signaling 1 function. J. Immunol. 2004, 172:7510-7518.
25. Flowers L.O., Subramaniam P.S., Johnson H.M. A SOCS-1 peptide mimetic inhibits both constitutive and IL-6 induced activation of STAT3 in prostate cancer cells. Oncogene 2005, 24:2114-2120.
26. Friedman B., Scherer S.S., Rudge J.S., Helgren M., Morrisey D., McClain J., Wang D.Y., Wiegand S.J., Furth M.E., Lindsay R.M., et al. Regulation of ciliary neurotrophic factor expression in myelin-related Schwann cells in vivo. Neuron 1992, 9:295-305.
27. Fry E.J., Ho C., David S. A role for Nogo receptor in macrophage clearance from injured peripheral nerve. Neuron 2007, 53:649-662.
28. Fujimoto M., Naka T. Regulation of cytokine signaling by SOCS family molecules. Trends Immunol. 2003, 24:659-666.
29. Hanada T., Kinjyo I., Inagaki-Ohara K., Yoshimura A. Negative regulation of cytokine signaling by CIS/SOCS family proteins and their roles in inflammatory diseases. Rev. Physiol. Biochem. Pharmacol. 2003, 149:72-86.
30. Hilton D.J. Negative regulators of cytokine signal transduction. Cell Mol. Life Sci. 1999, 55:1568-1577.
31. Ito Y., Yamamoto M., Li M., Doyu M., Tanaka F., Mutch T., Mitsuma T., Sobue G. Differential temporal expression of mRNAs for ciliary neurotrophic factor (CNTF), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and their receptors (CNTFR alpha, LIFR beta, IL-6R alpha and gp130) in injured peripheral nerves. Brain Res. 1998, 793:321-327.
32. Johnston J.A. Are SOCS suppressors, regulators, and degraders?. J. Leukoc. Biol. 2004, 75:743-748.
33. Kinjyo I., Hanada T., Inagaki-Ohara K., Mori H., Aki D., Ohishi M., Yoshida H., Kubo M., Yoshimura A. SOCS1/JAB is a negative regulator of LPS-induced macrophage activation. Immunity 2002, 17:583-591.
34. Kirsch M., Terheggen U., Hofmann H.D. Ciliary neurotrophic factor is an early lesion-induced retrograde signal for axotomized facial motoneurons. Mol. Cell Neurosci. 2003, 24:130-138.
35. Korompilias A.V., Chen L.E., Seaber A.V., Urbaniak J.R. Interleukin-1 beta promotes functional recovery of crushed peripheral nerve. J. Orthop. Res. 1999, 17:714-719.
36. Kubo M., Hanada T., Yoshimura A. Suppressors of cytokine signaling and immunity. Nat. Immunol. 2003, 4:1169-1176.
37. Lacroix S., Chang L., Rose-John S., Tuszynski M.H. Delivery of hyper-interleukin-6 to the injured spinal cord increases neutrophil and macrophage infiltration and inhibits axonal growth. J. Comp. Neurol. 2002, 454:213-228.
38. Lang R., Pauleau A.L., Parganas E., Takahashi Y., Mages J., Ihle J.N., Rutschman R., Murray P.J. SOCS3 regulates the plasticity of gp130 signaling. Nat. Immunol. 2003, 4:546-550.
39. Leskovar A., Moriarty L.J., Turek J.J., Schoenlein I.A., Borgens R.B. The macrophage in acute neural injury: changes in cell numbers over time and levels of cytokine production in mammalian central and peripheral nervous systems. J. Exp. Biol. 2000, 203(Pt. 12):1783-1795.
40. Liefner M., Siebert H., Sachse T., Michel U., Kollias G., Bruck W. The role of TNF-alpha during Wallerian degeneration. J. Neuroimmunol. 2000, 108:147-152.
41. Mansell A., Smith R., Doyle S.L., Gray P., Fenner J.E., Crack P.J., Nicholson S.E., Hilton D.J., O'Neill L.A., Hertzog P.J. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat. Immunol. 2006, 7:148-155.
42. Metcalf D., Alexander W.S., Elefanty A.G., Nicola N.A., Hilton D.J., Starr R., Mifsud S., Di Rago L. Aberrant hematopoiesis in mice with inactivation of the gene encoding SOCS-1. Leukemia 1999, 13:926-934.
43. Metcalf D., Mifsud S., Di Rago L., Nicola N.A., Hilton D.J., Alexander W.S. Polycystic kidneys and chronic inflammatory lesions are the delayed consequences of loss of the suppressor of cytokine signaling-1 (SOCS-1). Proc. Natl. Acad. Sci. U. S. A. 2002, 99:943-948.
44. Miao T., Wu D., Zhang Y., Bo X., Subang M.C., Wang P., Richardson P.M. Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J. Neurosci. 2006, 26:9512-9519.
45. Mueller M., Leonhard C., Wacker K., Ringelstein E.B., Okabe M., Hickey W.F., Kiefer R. Macrophage response to peripheral nerve injury: the quantitative contribution of resident and hematogenous macrophages. Lab. Invest. 2003, 83:175-185.
46. Mujtaba M.G., Flowers L.O., Patel C.B., Patel R.A., Haider M.I., Johnson H.M. Treatment of mice with the suppressor of cytokine signaling-1 mimetic peptide, tyrosine kinase inhibitor peptide, prevents development of the acute form of experimental allergic encephalomyelitis and induces stable remission in the chronic relapsing/remitting form. J. Immunol. 2005, 175:5077-5086.
47. Murphy P.G., Borthwick L.S., Johnston R.S., Kuchel G., Richardson P.M. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J. Neurosci. 1999, 19:3791-3800.
48. Perrin F.E., Lacroix S., Aviles-Trigueros M., David S. Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1alpha and interleukin-1beta in Wallerian degeneration. Brain 2005, 128:854-866.
49. Robb L., Boyle K., Rakar S., Hartley L., Lochland J., Roberts A.W., Alexander W.S., Metcalf D. Genetic reduction of embryonic leukemia-inhibitory factor production rescues placentation in SOCS3-null embryos but does not prevent inflammatory disease. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:16333-16338.
50. Sahenk Z., Seharaseyon J., Mendell J.R. CNTF potentiates peripheral nerve regeneration. Brain Res. 1994, 655:246-250.
51. Sakamoto H., Kinjyo I., Yoshimura A. The janus kinase inhibitor, Jab/SOCS-1, is an interferon-gamma inducible gene and determines the sensitivity to interferons. Leuk. Lymphoma 2000, 38:49-58.
52. Schafer M., Fruttiger M., Montag D., Schachner M., Martini R. Disruption of the gene for the myelin-associated glycoprotein improves axonal regrowth along myelin in C57BL/Wlds mice. Neuron 1996, 16:1107-1113.
53. Sendtner M., Gotz R., Holtmann B., Thoenen H. Endogenous ciliary neurotrophic factor is a lesion factor for axotomized motoneurons in adult mice. J. Neurosci. 1997, 17:6999-7006.
54. Sendtner M., Stockli K.A., Thoenen H. Synthesis and localization of ciliary neurotrophic factor in the sciatic nerve of the adult rat after lesion and during regeneration. J. Cell Biol. 1992, 118:139-148.
55. Shamash S., Reichert F., Rotshenker S. The cytokine network of Wallerian degeneration: tumor necrosis factor-alpha, interleukin-1alpha, and interleukin-1beta. J. Neurosci. 2002, 22:3052-3060.
56. Shen Y.J., DeBellard M.E., Salzer J.L., Roder J., Filbin M.T. Myelin-associated glycoprotein in myelin and expressed by Schwann cells inhibits axonal regeneration and branching. Mol. Cell Neurosci. 1998, 12:79-91.
57. Shuai K., Liu B. Regulation of JAK-STAT signalling in the immune system. Nat. Rev. Immunol. 2003, 3:900-911.
58. Starr R., Hilton D.J. SOCS: suppressors of cytokine signalling. Int. J. Biochem. Cell Biol. 1998, 30:1081-1085.
59. Starr R., Willson T.A., Viney E.M., Murray L.J., Rayner J.R., Jenkins B.J., Gonda T.J., Alexander W.S., Metcalf D., Nicola N.A., Hilton D.J. A family of cytokine-inducible inhibitors of signalling. Nature 1997, 387:917-921.
60. Stoll G., Jander S., Myers R.R. Degeneration and regeneration of the peripheral nervous system: from Augustus Waller's observations to neuroinflammation. J. Peripher. Nerv. Syst. 2002, 7:13-27.
61. Subang M.C., Richardson P.M. Influence of injury and cytokines on synthesis of monocyte chemoattractant protein-1 mRNA in peripheral nervous tissue. Eur. J. Neurosci. 2001, 13:521-528.
62. Subang M.C., Richardson P.M. Synthesis of leukemia inhibitory factor in injured peripheral nerves and their cells. Brain Res. 2001, 900:329-331.
63. Taskinen H.S., Roytta M. The dynamics of macrophage recruitment after nerve transection. Acta Neuropathol. 1997, 93:252-259.
64. Taskinen H.S., Roytta M. Increased expression of chemokines (MCP-1, MIP-1alpha, RANTES) after peripheral nerve transection. J. Peripher. Nerv. Syst. 2000, 5:75-81.
65. Taskinen H.S., Olsson T., Bucht A., Khademi M., Svelander L., Roytta M. Peripheral nerve injury induces endoneurial expression of IFN-gamma, IL-10 and TNF-alpha mRNA. J. Neuroimmunol. 2000, 102:17-25.
66. Toews A.D., Barrett C., Morell P. Monocyte chemoattractant protein 1 is responsible for macrophage recruitment following injury to sciatic nerve. J. Neurosci. Res. 1998, 53:260-267.
67. Waller A. Experiments on the section of glossopharyngeal and hypoglossal nerves of the frog and observations of the alternatives produced thereby in the structure of their primitive fibers. Philos. Trans. R. Soc. Lond. 1850, 140:423.
68. Wang X.Q., Peng Y.P., Lu J.H., Cao B.B., Qiu Y.H. Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci. Lett. 2009, 450:122-126.
69. Yasukawa H., Misawa H., Sakamoto H., Masuhara M., Sasaki A., Wakioka T., Ohtsuka S., Imaizumi T., Matsuda T., Ihle J.N., Yoshimura A. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J. 1999, 18:1309-1320.
70. Yoshimura A., Mori H., Ohishi M., Aki D., Hanada T. Negative regulation of cytokine signaling influences inflammation. Curr. Opin. Immunol. 2003, 15:704-708.
71. Yoshimura A., Ohishi H.M., Aki D., Hanada T. Regulation of TLR signaling and inflammation by SOCS family proteins. J. Leukoc. Biol. 2004, 75:422-427.
72. Zhang J., Lineaweaver W.C., Oswald T., Chen Z., Zhang F. Ciliary neurotrophic factor for acceleration of peripheral nerve regeneration: an experimental study. J. Reconstr. Microsurg. 2004, 20:323-327.
73. Zhong J., Dietzel I.D., Wahle P., Kopf M., Heumann R. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J. Neurosci. 1999, 19:4305-4313.